At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 10 enrolled
Drug / intervention
bariatric surgery +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Preliminary Comparison of the Blood Levels of Medications in Obese Subjects Compared to Post-Gastric Bypass Subjects
Neuropsychiatric Research Institute, Fargo, North Dakota·interventional·Posted Nov 18, 2009·Updated Mar 31, 2014
In Brief
A Phase 3 clinical trial evaluating bariatric surgery and control for Obesity. Completed, enrolled 10 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the difference, if any, in the area under the sertraline plasma level time curve (AUC) between patients who are nine to fifteen months post Roux-en-Y Bariatric Surgery and control subjects matched for body mass index (BMI), age and gender.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity
CountriesUnited States
CollaboratorsUniversity of North Dakota
Timeline
Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2009
First PostedNov 2009
Primary CompletionApr 2010
TodayJul 2026
First PostedNov 18, 2009
Enrollment StartFeb 1, 2009
Primary CompletionApr 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 16.6 years ago
Interventions
bariatric surgeryprocedure
Roux en Y bariatric surgery
controlother
No surgery